Mattessich Antony C. 4
4 · OCULAR THERAPEUTIX, INC · Filed Feb 1, 2023
Insider Transaction Report
Form 4
Mattessich Antony C.
DirectorPresident and C.E.O.
Transactions
- Award
Common Stock
2023-01-30+176,300→ 465,950 total - Award
Stock Option (Right to Buy)
2023-01-30+536,900→ 536,900 totalExercise: $3.88Exp: 2033-01-29→ Common Stock (536,900 underlying)
Footnotes (3)
- [F1]On January 30, 2023, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
- [F2]Includes 363,050 shares of common stock of the Company underlying unvested RSUs.
- [F3]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.